SlideShare une entreprise Scribd logo
1  sur  34
Epidemiology of CHD risk factors in Saudi Arabia Dr. Alaa Elalem Medical Department Pfizer, Jeddah, Saudi Arabia
 
 
 
 
Young population 79 % under age of 40 42 % under age of 20 16 %at age of  40-60 5  % over age of  60 WHR2006
Life expectancy at birth WHR 2006 Rank Country Life expectancy at birth  ( years) 1 San Marino 82 3 Japan 82 20 Germany 79 28 USA 78 38 UAE 77 61 Syria 72 80 Saudi Arabia 71 88 Turkey 71 107 Egypt 68 192 Zimbabwe 36
Global distribution of healthcare Physicians WHR 2006 Rank Country Physician Density per 1000 1 San Marino 47.35 / 1990 26 Germany 3.37 / 2003 47 USA 2.56 / 2000 62 UAE 2.02 / 2001 64 Japan 1.98 / 2002 76 Syria 1.40 / 2001 77 Saudi Arabia 1.30 / 2004 79 Turkey 1.35 / 2003 120 Egypt 0.54 / 2003 192 Malawi 0.02 / 2004
Global distribution of healthcare Pharmacists WHR 2006 Rank Country Pharmacist Density per 1000 1 Jordan 3.14 / 2004 5 Japan 2.21 / 2002 19 USA 0.88 / 2000 37 Germany 0.58 / 2003 45 Syria 0.52 / 2001 59 UAE 0.38 / 2001 63 Turkey 0.32 / 2003 76 Saudi Arabia 0.22 / 2004 94 Egypt 0.10 / 2004 161 Somalia (8) 0.00 / 1997 162 Cuba 0
Global distribution of healthcare Nurses WHR 2006 Rank Country Nurses density per 1000 1 San Marino 95.48 / 1990 15 Germany 9.72 / 2003 19 U.S.A. 9.37 / 2000 27 Japan 7.79 / 2002 60 U.A.E. 4.18 / 2001 88 Saudi Arabia 2.97 / 2004 104 Egypt 2.00 / 2004 106 Syria 1.94 / 2001 111 Turkey 1.70 / 2003 190 Bangladesh 0.14 / 2004
Healthcare expenditure indicators WHR 2006 Rank Country Per Capital Total Expenditure on Health at international dollar Rate (US$)- 2003 1 USA 5711 8 Germany 3001 21 Japan 2244 54 UAE 623 59 Saudi Arabia 578 67 Turkey 528 108 Egypt 235 137 Syria 116 191 Democratic republic of Congo 14
Healthcare expenditure indicators WHR 2006 Rank Country Total Expenditure of Health as % of GDP -2003 1 USA 15.2 6 Germany 11.1 10 Lebanon 10.2 41 Japan 7.9 48 Turkey 7.6 97 Egypt 5.8 122 Syria 5.1 154 Saudi Arabia 4 175 UAE 3.3 191 Equatorial  Guinea 1.5
Health care expenditure  WHR 2006
Health care expenditure  WHR 2006
Top 10   cause of Death in K.S.A.
Top 10   cause of Death in K.S.A. 30 %
[object Object],[object Object],1-Al Balla SR,. J Trop Med Hyg 1993;96:157-62  2-Bamgboye EA, Saudi Med J 1993;13(1):8-13. ] .
C.H.D. Risk Factors ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],2- Non  Modifiable: 1- Modifiable : Age  Male gender Family History
Prevalence of Hypertension in Saudi Arabia AL-Nozha et al in a cross-sectional cluster sampling & house hold  survey on 13700 Saudis of both sexes Kingdomwide Ann Saudi Med, Vol 17, No2.1997
Comparative Prevalence of hypertension and the expected hypertension population in each country Journal of Hypertension 2005, Vol 23 No 6
Cost of Hypertension in S.A ,[object Object],[object Object]
Prevalence of dyslipidemia in Saudi Adults ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Al-Nozha MM.et al. Metabolic syndrome in Saudi Arabia. Saudi Med J 2005; 26 (12): 1918-1925
Prevalence of DM in Saudi Arabia
Prevalence of DM in Saudi Arabia
Prevalence of DM in Saudi Adults Overall prevalence rate of Diabetes Mellitus was is  23.7%  and IFG  14.1%  based on 1997 American Diabetes Association (ADA) criteria and adopted by the World Health Organization (WHO) in 1998  Al-Nozha MM et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 2004;25 (11): 1603-1610
 
 
General Mortality in Saudi diabetics 2000 Saudi diabetics ( Initial )
Prevalence of obesity in Saudi Adults
Prevalence of obesity in Saudi Adults
Prevalence of obesity in Saudi Adults
Prevalence of Metabolic Syndrome in Saudi Adults Overall prevalence rate of metabolic syndrome as defined by the Adult Treatment Panel (ATP) III in 2001 was  39.3%.
The prevalence of regular smokers in each country Journal of Hypertension 2005, Vol 23 No 6
“A Man is as Old as His Arteries” Dr Thomas Sydenham (1624-89 )

Contenu connexe

Tendances

hypertension and diabetes - risk factors for Myocardial infarction
hypertension and diabetes - risk factors for Myocardial infarctionhypertension and diabetes - risk factors for Myocardial infarction
hypertension and diabetes - risk factors for Myocardial infarction
adithya2115
 

Tendances (20)

SGLT2 inhibitors - what's new?
SGLT2 inhibitors - what's new?SGLT2 inhibitors - what's new?
SGLT2 inhibitors - what's new?
 
Sprint trial
Sprint trialSprint trial
Sprint trial
 
Empagliflozin, cardiovascular outcomes, and mortality in type 2 DM
Empagliflozin, cardiovascular outcomes, and mortality in type 2 DMEmpagliflozin, cardiovascular outcomes, and mortality in type 2 DM
Empagliflozin, cardiovascular outcomes, and mortality in type 2 DM
 
Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...
Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...
Achieving Treatment Outcome With DPP4i for Diabetic Patient "Efficacy Beyond ...
 
smoking cessation
smoking cessationsmoking cessation
smoking cessation
 
glyxambi
glyxambiglyxambi
glyxambi
 
Lifestyle Medicine
Lifestyle MedicineLifestyle Medicine
Lifestyle Medicine
 
Initiation And Incremental Dialysis
Initiation And Incremental DialysisInitiation And Incremental Dialysis
Initiation And Incremental Dialysis
 
Hypertension Guidelines JNC 8
Hypertension Guidelines JNC 8Hypertension Guidelines JNC 8
Hypertension Guidelines JNC 8
 
Crestor Presentation
Crestor PresentationCrestor Presentation
Crestor Presentation
 
hypertension and diabetes - risk factors for Myocardial infarction
hypertension and diabetes - risk factors for Myocardial infarctionhypertension and diabetes - risk factors for Myocardial infarction
hypertension and diabetes - risk factors for Myocardial infarction
 
Dapagliflozin
DapagliflozinDapagliflozin
Dapagliflozin
 
Approach to optimal diabetes care by Dr Shahajda Selim
Approach to optimal diabetes care by Dr Shahajda SelimApproach to optimal diabetes care by Dr Shahajda Selim
Approach to optimal diabetes care by Dr Shahajda Selim
 
Electronic Cigarettes and Vaping
Electronic Cigarettes and VapingElectronic Cigarettes and Vaping
Electronic Cigarettes and Vaping
 
Semaglutide journal club
Semaglutide journal clubSemaglutide journal club
Semaglutide journal club
 
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insightDipeptidyl peptidase inhibitors(DPP-IV): A deep insight
Dipeptidyl peptidase inhibitors(DPP-IV): A deep insight
 
New generation insulins
New generation insulinsNew generation insulins
New generation insulins
 
DAPT & Statin Fixed dose combination.pptx
DAPT & Statin Fixed dose combination.pptxDAPT & Statin Fixed dose combination.pptx
DAPT & Statin Fixed dose combination.pptx
 
Role of SGLT2i in cardio-renal protection
Role of SGLT2i in cardio-renal protectionRole of SGLT2i in cardio-renal protection
Role of SGLT2i in cardio-renal protection
 
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada SelimSGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
SGLT2 Inhibitors in Diabetes Management by Dr Shahjada Selim
 

En vedette

Veno occlusive disease
Veno occlusive diseaseVeno occlusive disease
Veno occlusive disease
derosaMSKCC
 
Obesity in The UAE
Obesity in The UAEObesity in The UAE
Obesity in The UAE
Abdulla993
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
Abhay Mange
 

En vedette (14)

Obesity
ObesityObesity
Obesity
 
ueda2012 advance trial-d.salah
ueda2012 advance trial-d.salahueda2012 advance trial-d.salah
ueda2012 advance trial-d.salah
 
Veno occlusive disease
Veno occlusive diseaseVeno occlusive disease
Veno occlusive disease
 
Obesity in The UAE
Obesity in The UAEObesity in The UAE
Obesity in The UAE
 
smoking
smokingsmoking
smoking
 
SPRINT trial
SPRINT trialSPRINT trial
SPRINT trial
 
Hypertension - Approach & Management
Hypertension - Approach & ManagementHypertension - Approach & Management
Hypertension - Approach & Management
 
National NCD Program in Oman
National NCD Program in OmanNational NCD Program in Oman
National NCD Program in Oman
 
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi ArabiaChronic diseases and their risk factors in the Kingdom of Saudi Arabia
Chronic diseases and their risk factors in the Kingdom of Saudi Arabia
 
What Is Population Health And How Does It Compare to Public Health
What Is Population Health And How Does It Compare to Public HealthWhat Is Population Health And How Does It Compare to Public Health
What Is Population Health And How Does It Compare to Public Health
 
Pulmonary hypertension
Pulmonary hypertensionPulmonary hypertension
Pulmonary hypertension
 
Smoking & periodontium
Smoking & periodontiumSmoking & periodontium
Smoking & periodontium
 
Obesity
ObesityObesity
Obesity
 
Obesity Presentation
Obesity PresentationObesity Presentation
Obesity Presentation
 

Similaire à Health Stats Ksa

Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine
Dr. Anees Alyafei
 
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...
Dr. Jair García-Guerrero
 
presentation de Chandralall Sookram
presentation de Chandralall Sookrampresentation de Chandralall Sookram
presentation de Chandralall Sookram
tsoret1
 
Regional epidemiology of hypertension in the Gulf
Regional epidemiology of hypertension in the GulfRegional epidemiology of hypertension in the Gulf
Regional epidemiology of hypertension in the Gulf
JAFAR ALSAID
 

Similaire à Health Stats Ksa (20)

Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...Ueda2016 metabolic syndrome in different population,which one is appropriate ...
Ueda2016 metabolic syndrome in different population,which one is appropriate ...
 
Part 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFPPart 1, MHFS,why to build MDHFP
Part 1, MHFS,why to build MDHFP
 
Ndei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes EpidemiologyNdei Cardiovascular Disease In Diabetes Epidemiology
Ndei Cardiovascular Disease In Diabetes Epidemiology
 
Makkah HF registry oct 2021
Makkah HF registry oct 2021Makkah HF registry oct 2021
Makkah HF registry oct 2021
 
Type 2 DM ; Metformin Best Partner
Type 2 DM ; Metformin Best PartnerType 2 DM ; Metformin Best Partner
Type 2 DM ; Metformin Best Partner
 
Diabetes
DiabetesDiabetes
Diabetes
 
Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine Metabolic syndrome in Community Medicine
Metabolic syndrome in Community Medicine
 
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
 
The diabetic foot disorder in arabs countries a neglected clinical problem
The diabetic foot disorder in arabs countries a neglected clinical problemThe diabetic foot disorder in arabs countries a neglected clinical problem
The diabetic foot disorder in arabs countries a neglected clinical problem
 
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...
Epidemiología de la Resistencia a la Insulina, Diabetes Mellitus y Enfermedad...
 
Ueda 2016 diabetes atlas - nam cho
Ueda 2016 diabetes atlas  - nam choUeda 2016 diabetes atlas  - nam cho
Ueda 2016 diabetes atlas - nam cho
 
د فيصل الناصر
د فيصل الناصرد فيصل الناصر
د فيصل الناصر
 
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
 
presentation de Chandralall Sookram
presentation de Chandralall Sookrampresentation de Chandralall Sookram
presentation de Chandralall Sookram
 
Coronary heart disease - epidemiology
Coronary heart disease - epidemiologyCoronary heart disease - epidemiology
Coronary heart disease - epidemiology
 
Abbotsford feb 26 2014
Abbotsford feb 26 2014Abbotsford feb 26 2014
Abbotsford feb 26 2014
 
Regional epidemiology of hypertension in the Gulf
Regional epidemiology of hypertension in the GulfRegional epidemiology of hypertension in the Gulf
Regional epidemiology of hypertension in the Gulf
 
Atherogenic effects ofDiabetic Dyslipidemia.ppsx
Atherogenic effects ofDiabetic Dyslipidemia.ppsxAtherogenic effects ofDiabetic Dyslipidemia.ppsx
Atherogenic effects ofDiabetic Dyslipidemia.ppsx
 
ueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammedueda2012 do we still need high doses-d.mohammed
ueda2012 do we still need high doses-d.mohammed
 
ueda2011 diabetes in arb-d.nabil
ueda2011 diabetes in arb-d.nabilueda2011 diabetes in arb-d.nabil
ueda2011 diabetes in arb-d.nabil
 

Plus de hospital

Reading and interpreting Holter2023.pptx
Reading and interpreting Holter2023.pptxReading and interpreting Holter2023.pptx
Reading and interpreting Holter2023.pptx
hospital
 
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.ppt
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.pptLearning case of strongly positive PET-CT Rubidium 82 on all parameters.ppt
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.ppt
hospital
 
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...
hospital
 

Plus de hospital (20)

Nuclear cases Saturday 2023.pptx
Nuclear cases Saturday 2023.pptxNuclear cases Saturday 2023.pptx
Nuclear cases Saturday 2023.pptx
 
2023 HF p EF.pptx
2023 HF p EF.pptx2023 HF p EF.pptx
2023 HF p EF.pptx
 
SURGICAL MANGEMNT of VHD 2023fffffffff.pptx
SURGICAL MANGEMNT of VHD 2023fffffffff.pptxSURGICAL MANGEMNT of VHD 2023fffffffff.pptx
SURGICAL MANGEMNT of VHD 2023fffffffff.pptx
 
Reading and interpreting Holter2023.pptx
Reading and interpreting Holter2023.pptxReading and interpreting Holter2023.pptx
Reading and interpreting Holter2023.pptx
 
Complications_of_Diabetes.ppt
Complications_of_Diabetes.pptComplications_of_Diabetes.ppt
Complications_of_Diabetes.ppt
 
SURGICAL MANGEMNT of VHD 2023.pptx
SURGICAL MANGEMNT of VHD 2023.pptxSURGICAL MANGEMNT of VHD 2023.pptx
SURGICAL MANGEMNT of VHD 2023.pptx
 
the worst Medical Errors and how to mange them.pptx
the worst  Medical Errors and how to mange them.pptxthe worst  Medical Errors and how to mange them.pptx
the worst Medical Errors and how to mange them.pptx
 
Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...
Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...
Radionuclide Imaging of Cardiac Amyloidosis and SarcoidosisFELLOWS LECTUREupd...
 
End Organ Damage In HypertensionDARB.pptx
End Organ Damage In HypertensionDARB.pptxEnd Organ Damage In HypertensionDARB.pptx
End Organ Damage In HypertensionDARB.pptx
 
DELIVER delivered 2022.pptx
DELIVER delivered 2022.pptxDELIVER delivered 2022.pptx
DELIVER delivered 2022.pptx
 
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction REV...
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction  REV...Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction  REV...
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction REV...
 
Acetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptx
Acetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptxAcetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptx
Acetazolamide in Acute Decompensated Heart Failure with Volume ADVOR.pptx
 
MRCP SUDAN QUESTIONS.pptx
MRCP SUDAN QUESTIONS.pptxMRCP SUDAN QUESTIONS.pptx
MRCP SUDAN QUESTIONS.pptx
 
DM LECTURE PROJECT.pptx
DM LECTURE  PROJECT.pptxDM LECTURE  PROJECT.pptx
DM LECTURE PROJECT.pptx
 
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.ppt
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.pptLearning case of strongly positive PET-CT Rubidium 82 on all parameters.ppt
Learning case of strongly positive PET-CT Rubidium 82 on all parameters.ppt
 
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...
The Role of PET-CT imaging in the diagnosis of cardiac sarcoidosis post cardi...
 
Diabetes mellitus and vascular disease 2022 FINALD.pptx
Diabetes mellitus and vascular disease 2022 FINALD.pptxDiabetes mellitus and vascular disease 2022 FINALD.pptx
Diabetes mellitus and vascular disease 2022 FINALD.pptx
 
Nuc part BBBB.pptx
Nuc part BBBB.pptxNuc part BBBB.pptx
Nuc part BBBB.pptx
 
Non Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptxNon Invasive testing of myocardial ischemia AA.pptx
Non Invasive testing of myocardial ischemia AA.pptx
 
Inherited aortopathy2022
Inherited aortopathy2022Inherited aortopathy2022
Inherited aortopathy2022
 

Dernier

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
PECB
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
Chris Hunter
 

Dernier (20)

PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Class 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdfClass 11th Physics NEET formula sheet pdf
Class 11th Physics NEET formula sheet pdf
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17  How to Extend Models Using Mixin ClassesMixin Classes in Odoo 17  How to Extend Models Using Mixin Classes
Mixin Classes in Odoo 17 How to Extend Models Using Mixin Classes
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
2024-NATIONAL-LEARNING-CAMP-AND-OTHER.pptx
 
Grant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy ConsultingGrant Readiness 101 TechSoup and Remy Consulting
Grant Readiness 101 TechSoup and Remy Consulting
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Making and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdfMaking and Justifying Mathematical Decisions.pdf
Making and Justifying Mathematical Decisions.pdf
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
Ecological Succession. ( ECOSYSTEM, B. Pharmacy, 1st Year, Sem-II, Environmen...
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Role Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptxRole Of Transgenic Animal In Target Validation-1.pptx
Role Of Transgenic Animal In Target Validation-1.pptx
 

Health Stats Ksa

  • 1. Epidemiology of CHD risk factors in Saudi Arabia Dr. Alaa Elalem Medical Department Pfizer, Jeddah, Saudi Arabia
  • 2.  
  • 3.  
  • 4.  
  • 5.  
  • 6. Young population 79 % under age of 40 42 % under age of 20 16 %at age of 40-60 5 % over age of 60 WHR2006
  • 7. Life expectancy at birth WHR 2006 Rank Country Life expectancy at birth ( years) 1 San Marino 82 3 Japan 82 20 Germany 79 28 USA 78 38 UAE 77 61 Syria 72 80 Saudi Arabia 71 88 Turkey 71 107 Egypt 68 192 Zimbabwe 36
  • 8. Global distribution of healthcare Physicians WHR 2006 Rank Country Physician Density per 1000 1 San Marino 47.35 / 1990 26 Germany 3.37 / 2003 47 USA 2.56 / 2000 62 UAE 2.02 / 2001 64 Japan 1.98 / 2002 76 Syria 1.40 / 2001 77 Saudi Arabia 1.30 / 2004 79 Turkey 1.35 / 2003 120 Egypt 0.54 / 2003 192 Malawi 0.02 / 2004
  • 9. Global distribution of healthcare Pharmacists WHR 2006 Rank Country Pharmacist Density per 1000 1 Jordan 3.14 / 2004 5 Japan 2.21 / 2002 19 USA 0.88 / 2000 37 Germany 0.58 / 2003 45 Syria 0.52 / 2001 59 UAE 0.38 / 2001 63 Turkey 0.32 / 2003 76 Saudi Arabia 0.22 / 2004 94 Egypt 0.10 / 2004 161 Somalia (8) 0.00 / 1997 162 Cuba 0
  • 10. Global distribution of healthcare Nurses WHR 2006 Rank Country Nurses density per 1000 1 San Marino 95.48 / 1990 15 Germany 9.72 / 2003 19 U.S.A. 9.37 / 2000 27 Japan 7.79 / 2002 60 U.A.E. 4.18 / 2001 88 Saudi Arabia 2.97 / 2004 104 Egypt 2.00 / 2004 106 Syria 1.94 / 2001 111 Turkey 1.70 / 2003 190 Bangladesh 0.14 / 2004
  • 11. Healthcare expenditure indicators WHR 2006 Rank Country Per Capital Total Expenditure on Health at international dollar Rate (US$)- 2003 1 USA 5711 8 Germany 3001 21 Japan 2244 54 UAE 623 59 Saudi Arabia 578 67 Turkey 528 108 Egypt 235 137 Syria 116 191 Democratic republic of Congo 14
  • 12. Healthcare expenditure indicators WHR 2006 Rank Country Total Expenditure of Health as % of GDP -2003 1 USA 15.2 6 Germany 11.1 10 Lebanon 10.2 41 Japan 7.9 48 Turkey 7.6 97 Egypt 5.8 122 Syria 5.1 154 Saudi Arabia 4 175 UAE 3.3 191 Equatorial Guinea 1.5
  • 15. Top 10 cause of Death in K.S.A.
  • 16. Top 10 cause of Death in K.S.A. 30 %
  • 17.
  • 18.
  • 19. Prevalence of Hypertension in Saudi Arabia AL-Nozha et al in a cross-sectional cluster sampling & house hold survey on 13700 Saudis of both sexes Kingdomwide Ann Saudi Med, Vol 17, No2.1997
  • 20. Comparative Prevalence of hypertension and the expected hypertension population in each country Journal of Hypertension 2005, Vol 23 No 6
  • 21.
  • 22.
  • 23. Prevalence of DM in Saudi Arabia
  • 24. Prevalence of DM in Saudi Arabia
  • 25. Prevalence of DM in Saudi Adults Overall prevalence rate of Diabetes Mellitus was is 23.7% and IFG 14.1% based on 1997 American Diabetes Association (ADA) criteria and adopted by the World Health Organization (WHO) in 1998 Al-Nozha MM et al. Diabetes mellitus in Saudi Arabia. Saudi Med J 2004;25 (11): 1603-1610
  • 26.  
  • 27.  
  • 28. General Mortality in Saudi diabetics 2000 Saudi diabetics ( Initial )
  • 29. Prevalence of obesity in Saudi Adults
  • 30. Prevalence of obesity in Saudi Adults
  • 31. Prevalence of obesity in Saudi Adults
  • 32. Prevalence of Metabolic Syndrome in Saudi Adults Overall prevalence rate of metabolic syndrome as defined by the Adult Treatment Panel (ATP) III in 2001 was 39.3%.
  • 33. The prevalence of regular smokers in each country Journal of Hypertension 2005, Vol 23 No 6
  • 34. “A Man is as Old as His Arteries” Dr Thomas Sydenham (1624-89 )